<DOC>
<DOCNO>EP-0611767</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Heterocyclic substituted phenyl-cyclohexan carboxylic acid derivatives as angiotensin II antagonists
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D47100	C07D20902	C07D20912	A61P900	A61K314188	A61P900	A61K31415	A61K31403	A61K31435	C07D20910	C07D40300	C07D20908	A61P910	C07D23518	C07D23500	A61K31404	C07D40310	A61P912	A61K31415	C07D20900	A61P4300	C07D47104	A61P4300	C07D20930	A61K3140	C07D23510	A61K3140	A61K31403	C07D23508	A61K31435	A61K314164	A61K314184	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	C07D	A61P	A61K	A61P	A61K	A61K	A61K	C07D	C07D	C07D	A61P	C07D	C07D	A61K	C07D	A61P	A61K	C07D	A61P	C07D	A61P	C07D	A61K	C07D	A61K	A61K	C07D	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D471	C07D209	C07D209	A61P9	A61K31	A61P9	A61K31	A61K31	A61K31	C07D209	C07D403	C07D209	A61P9	C07D235	C07D235	A61K31	C07D403	A61P9	A61K31	C07D209	A61P43	C07D471	A61P43	C07D209	A61K31	C07D235	A61K31	A61K31	C07D235	A61K31	A61K31	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Derivatives of the formula 
<
IMAGE
>
  in which     B and D together form a radical of the formula 
<
IMAGE
>
     T is a radical of the formula 
<
IMAGE
>
  or tetrazolyl.   The compounds can be employed as active ingredients in medicaments for the treatment of arterial high blood pressure and atherosclerosis.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Heterocyclically substituted phenyl-cyclohexane-carboxylic
acid derivatives of the general formula

(I)


in which

A
represents hydrogen or aryl having 6 to 10
carbon atoms, which is optionally substituted by

hydroxyl, halogen or trifluoromethyl or by
straight-chain or branched alkyl or alkoxy in

each case having up to 6 carbon atoms, or

represents straight-chain or branched alkyl or
alkenyl in each case having up to 8 carbon

atoms, or

represents cycloalkyl having 3 to 8 carbon
atoms, 
E
represents a nitrogen atom or a radical of the
formula -CR
1
,

in which
R
1
has the abovementioned meaning of A and
is identical to or different from this,
B and D
together form a radical of the formula


in which
R
2
, R
3
 and R
4
are identical or different and
have the abovementioned meaning of A and

are identical to or different from this,
or denote halogen,
L
represents hydrogen, halogen, nitro, hydroxyl,
trifluoromethyl, trifluoromethoxy, straight-chain

or branched alkyl, alkoxy or
alkoxycarbonyl in each case having up to 6

carbon atoms, cyano or carboxyl,
T
represents a radical of the formula 

-CO
2
R
5
, -CO-NR
6
SO
2
R
7
 or

in which
R
5
denotes hydrogen, straight-chain or
branched alkyl having up to 8 carbon

atoms, cycloalkyl having 3 to 7 carbon
atoms, or phenyl,
R
6
 and R
8
are identical or different and denote
hydrogen or straight-chain or branched

alkyl having up to 6 carbon atoms,
R
7
denotes trifluoromethyl or straight-chain
or branched alkyl having up to 6 carbon

atoms, or benzyl or phenyl, each of which
is optionally substituted by straight-chain

alkyl having up to 6 carbon atoms,
R
9
 denotes aryl having 6 to 10 carbon atoms,
which is optionally substituted up to 2

times by identical or different substituents
from the group consisting of

halogen, hydroxyl, straight-chain or
branched alkyl, alkoxy or alkoxycarbonyl

in each case having up to 6 carbon atoms,
carboxyl, phenoxy and C
3
-C
6
-cycloalkoxy,
R
10
denotes a group of the formula -CH
2
-OR
11
,
-CO
2
R
12
, -CO-NR
13
R
14
 or pyridyl,

in which 
R
11
denotes hydrogen or straight-chain or
branched alkyl having up to 8 carbon

atoms,
R
12
denotes hydrogen, straight-chain or
branched alkyl having up to 8 carbon

atoms, or phenyl or cycloalkyl having 3
to 6 carbon atoms,
R
13
 and R
14
are identical or different and denote
hydrogen, straight-chain or branched

alkyl having up to 8 carbon atoms, or
phenyl,

or
T
represents tetrazolyl, which is optionally
substituted by triphenylmethyl or straight-chain

or branched alkyl having up to 4 carbon atoms,

if appropriate in a stereoisomeric form, and their
physiologically acceptable salts.
Beterocyclically substituted phenyl-cyclohexane-carboxylic
acid derivatives according to Claim 1

in which

A
represents hydrogen or phenyl which is
optionally substituted by hydroxyl, fluorine,

chlorine, bromine or trifluoromethyl or by
straight-chain or branched alkyl or alkoxy in

each case having up to 4 carbon atoms, or
 
represents straight-chain or branched alkyl or

alkenyl in each case having up to 6 carbon
atoms, or

represents cyclopropyl, cyclobutyl, cyclopentyl,
cyclohexyl
 or cycloheptyl,
E
represents a nitrogen atom or a radical of the
formula -CR
1
,

in which
R
1
has the abovementioned meaning of A and
is identical to or different from this,
B and D
together form a radical of the formula


in which
R
2
, R
3
 and R
4
are identical or different and
have the abovementioned meaning of A and

are identical to or different from this,
or denote fluorine, chlorine or bromine, 
L
represents hydrogen, fluorine, chlorine,
bromine, trifluoromethyl, carboxyl or straight-chain

or branched alkyl, alkoxy or
alkoxycarbonyl in each case having up to 4

carbon atoms,
T
represents a radical of the formulae

-CO
2
R
5
, -CO-NR
6
SO
2
R
7
 or

in which
R
5
denotes hydrogen, straight-chain or
branched alkyl having up to 6 carbon

atoms, cyclopropyl, cyclopentyl, cyclohexyl
or phenyl,
R
6
 and R
8
are identical or different and denote
hydrogen or straight-chain or branched

alkyl having up to 4 carbon atoms,
R
7
denotes trifluoromethyl or straight-chain
or branched alkyl having up to 4 carbon

atoms, or benzyl or phenyl, each of which
is optionally substituted by straight-chain

or branched alkyl having up to 4
carbon atoms,

R
9
 denotes phenyl which is optionally substituted
by fluorine, chlorine, bromine,

hydroxyl, straight-chain or branched
alkyl, alkoxy or alkoxycarbonyl in each

case having up to 4 carbon atoms, carboxyl
or phenoxy, 
R
10
denotes a group of the formula -CH
2
-OR
11
,
-CO
2
R
12
, -CO-NR
13
R
14
 or pyridyl,

in which
R
11
denotes hydrogen or straight-chain or
branched alkyl having up to 6 carbon

atoms,
R
12
 denotes hydrogen, straight-chain or
branched alkyl having up to 6 carbon

atoms, phenyl, cyclopropyl, cyclopentyl
or cyclohexyl,
R
13
 and R
14
are identical or different and denote
hydrogen, straight-chain or branched

alkyl having up to 6 carbon atoms,
cyclopropyl, cyclopentyl, cyclohexyl or

phenyl,

or
T
represents tetrazolyl, which is optionally
substituted by triphenylmethyl or methyl,

if appropriate in a stereoisomeric form, and their
physiologically acceptable salts.
Heterocyclically substituted phenyl-cyclohexane-carboxylic
acid derivatives according to Claim 1

in which

A
represents hydrogen or
 
represents straight-chain or branched alkyl

having up to 4 carbon atoms, or

represents phenyl or cyclopropyl, cyclopentyl or
cyclohexyl,
E
represents a nitrogen atom,
B and D
together form a radical of the formula


in which
R
2
, R
3
 and R
4
are identical or different and
have the abovementioned meaning of A and

are identical to or different from this,
or denote fluorine, chlorine or bromine,
L
represents hydrogen, fluorine, chlorine, trifluoromethyl
or methyl,
T
represents a radical of the formula

-CO
2
R
5
, -CO-NR
6
SO
2
R
7
 or

in which
R
5
denotes hydrogen or straight-chain or
branched alkyl having up to 4 carbon

atoms, 
R
6
 and R
8
are identical or different and denote
hydrogen or methyl,
R
7
denotes trifluoromethyl or methyl, ethyl,
benzyl, p-tolyl or phenyl,
R
9
denotes phenyl which is optionally substituted
by fluorine, chlorine, bromine,

hydroxyl, straight-chain or branched
alkyl, alkoxy or alkoxycarbonyl in each

case having up to 3 carbon atoms,
carboxyl or phenoxy,
R
10
denotes a group of the formula -CH
2
-OR
11
,
-CO
2
R
12
, -CO-NR
13
R
14
 or pyridyl,

in which
R
11
denotes hydrogen or straight-chain or
branched alkyl having up to 4 carbon

atoms,
R
12
denotes hydrogen or straight-chain or
branched alkyl having up to 4 carbon

atoms,
R
13
 and R
14
are identical or different and denote
hydrogen or straight-chain or branched

alkyl having up to 4 carbon atoms,

or
T
represents tetrazolyl, which is optionally
substituted by triphenylmethyl or methyl,
 
if appropriate in a stereoisomeric form, and their

physiologically acceptable salts.
Heterocyclically substituted phenyl-cyclohexane-carboxylic
acid derivatives according to Claim 1

in which

A
represents hydrogen, straight-chain or branched
alkyl having up to 4 carbon atoms, or

represents phenyl or cyclopropyl,
E
represents a nitrogen atom,
B and D
together form a radical of the formula


in which
R
2
, R
3
 and R
4
are identical or different and
denote methyl, hydrogen, fluorine,

chlorine or bromine,
L
represents hydrogen, fluorine or chlorine,
T
represents a radical of the formula

-CO
2
R
5
, -CO-NR
6
SO
2
R
7
 or
 
in which
R
5
denotes hydrogen or straight-chain or
branched alkyl having up to 4 carbon

atoms,
R
6
 and R
8
are identical or different and denote
hydrogen or methyl,
R
7
denotes trifluoromethyl, methyl or
p-tolyl,
R
9
denotes phenyl which can be substituted
by fluorine or chlorine,

and
R
10
denotes a group of the formula -CH
2
OH or
-CONH
2
 or pyridyl,

or
T
represents tetrazolyl, which is optionally
substituted by triphenylmethyl,

if appropriate in a stereoisomeric form, and their
physiologically acceptable salts.
Heterocyclically substituted phenyl-cyclohexane-carboxylic
acid derivatives according to Claims 1

to 4 for use in the treatment of diseases.
Process for the preparation of heterocyclically
substituted phenyl-cyclohexane-carboxylic acid 

derivatives according to Claims 1 to 4, characterized
in that

compounds of the general formula (II)


in which

L
has the abovementioned meaning,
W
represents a typical leaving group such as, for
example, chlorine, bromine, iodine, tosylate or

mesylate, preferably bromine

and
X
represents C
1
-C
6
-alkoxycarbonyl or the triphenylmethyl-tetrazol-1-yl
group,

are reacted first with compounds of the general

formula (III)


in which 

A, B, D and E
have the abovementioned meaning,

in inert solvents, if appropriate in the presence
of a base and if appropriate under a protective gas

atmosphere, to give compounds of the general
formula (IV)



in which

A, B, D, L and X
have the abovementioned meaning,

and if appropriate starting from the corresponding
carboxylic acids, the products are subsequently

amidated in inert solvents, after prior hydrolysis
and/or activation, with sulphonamides or amines of

the general formulae (V) and (Va)


in which

R
6
, R
7
, R
8
, R
9
 and R
10
have the abovementioned

meaning,
 
if appropriate in the presence of a base and/or of

a dehydrating agent,

and in the case of the free tetrazoles, if appropriate
the triphenylmethyl group is removed by

customary methods using acids, preferably using
trifluoroacetic acid or hydrochloric acid in

dioxane,

if appropriate the stereoisomers are separated, and
in the case of the preparation of the

physiologically acceptable salts reacted with an
appropriate base or acid.
Medicaments containing at least one
heterocyclically substituted phenyl-cyclohexane-carboxylic

acid derivative according to Claims 1 to
4.
Medicaments according to Claim 7 for the treatment
of arterial hypertension and atherosclerosis.
Use of heterocyclically substituted phenyl-cyclohexane-carboxylic
acid derivatives according to

Claims 1 to 4 for the production of medicaments.
Process for the production of medicaments according
to Claim 7 or 11, characterized in that the heterocyclically

substituted phenyl-cyclohexane-carboxylic
acid derivatives are converted into a

suitable administration form, if appropriate with
the aid of suitable auxiliaries and excipients. 
Medicaments according to claim 7 for the treatment
of ischaemic cerebral diseases.
</CLAIMS>
</TEXT>
</DOC>
